Literature DB >> 4680813

Comparative clinical pharmacology of amoxicillin and ampicillin administered orally.

C Gordon, C Regamey, W M Kirby.   

Abstract

Ampicillin and amoxicillin (alpha-amino-p-hydroxybenzyl penicillin) were administered orally in 500-mg doses to eight fasting volunteers in a comparative study in which pharmacokinetic techniques were used. The absorption of amoxicillin was significantly better, as demonstrated by a higher mean peak serum concentration of 7.6 mug/ml as compared to 3.2 mug/ml for ampicillin, an average "area under the curve" that was approximately double that of ampicillin, and an 8-hr urinary recovery for amoxicillin of 60% as compared to 34% for ampicillin. Serum half-lives were the same for the two antibiotics, with values of 60.3 (+/-3.3) min for ampicillin and 61.3 (+/-5.6) min for amoxicillin. The latter drug gave measurable concentrations in the blood at 8 hr in all of eight volunteers, as compared to only three of eight with ampicillin.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4680813      PMCID: PMC444250          DOI: 10.1128/AAC.1.6.504

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  DICLOXACILLIN. IN VITRO AND PHARMACOLOGIC COMPARISONS WITH OXACILLIN AND CLOXACILLIN.

Authors:  C F GRAVENKEMPER; J V BENNETT; J L BRODIE; W M KIRBY
Journal:  Arch Intern Med       Date:  1965-09

2.  Ampicillin activity in vitro and absorption and excretion in normal young men.

Authors:  J O KLEIN; M FINLAND
Journal:  Am J Med Sci       Date:  1963-05       Impact factor: 2.378

3.  Absorption and excretion of "Penbritin".

Authors:  E T KNUDSEN; G N ROLINSON; S STEVENS
Journal:  Br Med J       Date:  1961-07-22

4.  Pharmacological studies of 6 (D(-) -amino-p-hydroxyphenylacetamido) penicillanic acid in humans.

Authors:  H C Neu; E B Winshell
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

5.  In vitro antimicrobial activity of 6(D(-) -amino-p-hydroxyphenylacetamido) penicillanic acid, a new semisynthetic penicillin.

Authors:  H C Neu; E B Winshell
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

6.  Clinical pharmacology of pivampicillin.

Authors:  E L Foltz; J W West; I H Breslow; H Wallick
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

7.  Clinical pharmacology of ampicillin and hetacillin.

Authors:  W M Kirby; A C Kind
Journal:  Ann N Y Acad Sci       Date:  1967-09-27       Impact factor: 5.691

8.  -amino-p-hydroxybenzylpenicillin (BRL 2333), a new semisynthetic penicillin: absorption and excretion in man.

Authors:  E A Croydon; R Sutherland
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

9.  -amino-p-hydroxybenzylpenicillin (BRL 2333), a new semisynthetic penicillin: in vitro evaluation.

Authors:  R Sutherland; G N Rolinson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

10.  Pharmacokinetics of ampicillin trihydrate, sodium ampicillin, and sodium dicloxacillin following intramuscular injection.

Authors:  J T Doluisio; J C LaPiana; L W Dittert
Journal:  J Pharm Sci       Date:  1971-05       Impact factor: 3.534

View more
  34 in total

1.  Triple crossover study on absorption and excretion of ampicillin, pivampicillin, and amoxycillin.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

Review 2.  Variations in amoxicillin pharmacokinetic/pharmacodynamic parameters may explain treatment failures in acute otitis media.

Authors:  Michael E Pichichero; Michael D Reed
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

3.  Penetration of cefamandole, cephalothin, and desacetylcephalothin into fibrin clots.

Authors:  M G Bergeron; B M Nguyen; S Trottier; L Gauvreau
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

4.  In vitro activity of clarithromycin against intracellular Helicobacter pylori.

Authors:  R Piccolomini; G Di Bonaventura; C Picciani; F Laterza; J Vecchiet; M Neri
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 5.  Influence of food and diet on gastrointestinal drug absorption: a review.

Authors:  P G Welling
Journal:  J Pharmacokinet Biopharm       Date:  1977-08

Review 6.  Amoxycillin: a preliminary report of its pharmokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 7.  Newer beta-lactam antibiotics.

Authors:  J M Hamilton-Miller; W Brumfitt
Journal:  Infection       Date:  1974       Impact factor: 3.553

8.  Treatment of bacterial meningitis with intravenous amoxicillin.

Authors:  C M Nolan; E G Chalhub; D G Nash; T Yamauchi
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

9.  A comparison of the pharmacokinetics of bacampicillin, ampicillin, amoxicillin, and cyclacillin: oral administration in infants and children.

Authors:  G M McCracken
Journal:  Bull N Y Acad Med       Date:  1983-06

10.  Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration.

Authors:  D A Spyker; R J Rugloski; R L Vann; W M O'Brien
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.